Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1992-9-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzamides,
http://linkedlifedata.com/resource/pubmed/chemical/Moclobemide,
http://linkedlifedata.com/resource/pubmed/chemical/Monoamine Oxidase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines,
http://linkedlifedata.com/resource/pubmed/chemical/brofaromine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0362-5664
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15 Suppl 1 Pt A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345A-346A
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
1992
|
pubmed:articleTitle |
Clinical pharmacology of reversible MAO-A inhibitors.
|
pubmed:affiliation |
Human Pharmacology Institute CIBA-GEIGY GmbH, Tübingen, Germany.
|
pubmed:publicationType |
Journal Article
|